Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Regulatory News In Brief

This article was originally published in The Gray Sheet

Executive Summary

PMA-supplement guidance

You may also be interested in...



FDA Manufacturing-Change Reviews Will Shift From Compliance Office To ODE

The move is in line with the agency’s intention to focus on the total product life-cycle, such that the same staffers that review an original marketing submission will look at the safety and effectiveness of manufacturing changes.

Regulatory News In Brief

Radiological health post-market offices moving to OIVD. FDA issues global engagement report. More regulatory news.

Massachusetts Device Makers Urge FDA To Abandon Controversial 510(k) Reform Proposals

Massachusetts device makers are pressing FDA to abandon the controversial 510(k) reform recommendations currently awaiting input from the Institute of Medicine.

Related Content

UsernamePublicRestriction

Register

MT030053

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel